• Feb 3, 2021
This week on Dr. Greg Davis on Medicine we highlight UK PATHways, a comprehensive opioid maintenance treatment program for pregnant women recovering from addiction and how it has managed to adapt through the COVID-19 pandemic. Director Jason Joy says the program was born out of a necessity to serve a large population of prenatal patients coming to UK with substance use disorders.
Listen
Credit Pete Comparoni | UK Photo.
Brooke Hudspeth, PharmD, is Chief Practice Officer (CPO) for the UK College of Pharmacy. Hudspeth, the acting secretary for the Kentucky Pharmacist Association (KphA) oversees all community pharmacy efforts for the college while working to elevate the care available to those in the Commonwealth.
Hudspeth is an alumnus of the college’s PharmD and Community Residency programs and serves as a preceptor for pharmacy students and residents. In addition, she is known for her collaboration with the American Pharmacists Association Foundation, The Kroger Co., and the Centers for Disease Control and Prevention (CDC) for her work on the National Diabetes Prevention Program (DPP). Hudspeth helped secure a $7.5M grant from the CDC to expand the National DPP to five states, using the model she developed for Kentucky.
Credit Pete Comparoni | UK Photo.
Brooke Hudspeth, PharmD, is Chief Practice Officer (CPO) for the UK College of Pharmacy. Hudspeth, the acting secretary for the Kentucky Pharmacist Association (KphA) oversees all community pharmacy efforts for the college while working to elevate the care available to those in the Commonwealth.
Hudspeth is an alumnus of the college’s PharmD and Community Residency programs and serves as a preceptor for pharmacy students and residents. In addition, she is known for her collaboration with the American Pharmacists Association Foundation, The Kroger Co., and the Centers for Disease Control and Prevention (CDC) for her work on the National Diabetes Prevention Program (DPP). Hudspeth helped secure a $7.5M grant from the CDC to expand the National DPP to five states, using the model she developed for Kentucky.
This week on Dr. Greg Davis on Medicine we talk with Lexington pediatrician Elizabeth Hawes about the unique needs and challenges of children and their
• Nov 11, 2020
The University of Kentucky, in partnership with Baptist Health Lexington and Norton Healthcare in Louisville, has been selected as a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study, called the ENSEMBLE trial, to evaluate Janssen’s investigational COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S. Dr. Greg speaks with UK Director of Clinical Operations Linda Rice about the effort.
Listen